Form 8-K - Current report:
SEC Accession No. 0001213900-25-042122
Filing Date
2025-05-12
Accepted
2025-05-12 17:24:09
Documents
18
Period of Report
2025-05-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0241711-8k_apimeds.htm   iXBRL 8-K 28114
2 UNDERWRITING AGREEMENT, DATED MAY 8, 2025, BETWEEN THE COMPANY AND D. BORAL CAPI ea024171101ex1-1_apimeds.htm EX-1.1 471273
3 REPRESENTATIVE'S WARRANTS, DATED MAY 12, 2025, TO JOSEPH T. RALLO ea024171101ex4-1_apimeds.htm EX-4.1 118449
4 FORM OF INDEMNIFICATION AGREEMENT ea024171101ex10-1_apimeds.htm EX-10.1 99414
5 PRESS RELEASE, DATED MAY 8, 2025 ea024171101ex99-1_apimeds.htm EX-99.1 13261
6 PRESS RELEASE, DATED MAY 12, 2025 ea024171101ex99-2_apimeds.htm EX-99.2 10936
  Complete submission text file 0001213900-25-042122.txt   1095615

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE apus-20250508.xsd EX-101.SCH 3017
8 XBRL LABEL FILE apus-20250508_lab.xml EX-101.LAB 34239
9 XBRL PRESENTATION FILE apus-20250508_pre.xml EX-101.PRE 22360
20 EXTRACTED XBRL INSTANCE DOCUMENT ea0241711-8k_apimeds_htm.xml XML 3698
Mailing Address 2 EAST BROAD STREET 2ND FLOOR HOPEWELL NJ 08525
Business Address 2 EAST BROAD STREET 2ND FLOOR HOPEWELL NJ 08525 609-751-4485
Apimeds Pharmaceuticals US, Inc. (Filer) CIK: 0001894525 (see all company filings)

EIN.: 851099700 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42545 | Film No.: 25936144
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)